Acta Scientific Paediatrics (ISSN: 2581-883X)

Case Report Volume 3 Issue 5

Hyperkinetic Syndrome in Adolescent with HIV-Infection

Borysova TP, Badogina LP*, Allahverdieva ZS and Samsonenko SV

SI “Dnepropetrovsk Medical Academy, Ministry of Health of Ukraine”, Dnipro, Ukraine

*Corresponding Author: Badogina LP, SI “Dnepropetrovsk Medical Academy, Ministry of Health of Ukraine”, Dnipro, Ukraine.

Received: February 27, 2020; Published: April 23, 2020


  A clinical case of a rare manifestation of HIV encephalopathy in a teenager in the form of generalized hyperkinesis is described. Differential diagnosis with acute rheumatic fever, systemic connective tissue disease, demyelinating diseases, tumors of the central nervous system, Wilson-Konovalov disease is presented.



  1. “HIV infection in Ukraine”. Newsletter 50 (2019): 86-88.
  2. “Assessment of the regional targeted social program on HIV/AIDS (analysis period 2009-2016) in Dnipropetrovsk region”. Report Kyiv (2018): 12-14.
  3. Evtushenko SK and Derevyanko IN. “Neuro-AIDS as one of the urgent problems of modern practical neurology”. International Neurological Journal9 (2006): 147-157.
  4. Gongora-Rivera F., et al. “The clinical spectrum of neurological manifestations in AIDS patients in Mexico”. Archives of Medical Research 4 (2000): 393-398.
  5. Martynova GP., et al. “A case of severe CNS damage in a child with HIV infection”. Childhood Infections 4 (2011): 69-70.
  6. Starets OO. “The course, factors of progression and treatment of HIV infection in children”. Odessa (2008): 44.
  7. Timchenko VN., et al. “Damage to the nervous system in HIV infection”. Childhood Infections 1 (2009): 32-35.
  8. Lowenthal ED., et al. “Neurologic and Psychiatric Manifestations of Pediatric HIV Infection”. HIV Curriculum for the Health Professional.
  9. Krel R. Central Nervous System Complications in HIV (2011).
  10. Donald KA., et al. “Neurologic complications of pediatric human immunodeficiency virus: implications for clinical practice and management challenges in the African setting”. Seminars in Pediatric Neurology 1 (2014): 3-11.
  11. Trillo-Pazos G., et al. “Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection”. Brain Pathology 2 (2003): 144-154.
  12. Manfredi R. “AIDS and Other Manifestations of HIV Infection”. Journal of the American Medical Association 11 (2005): 1393-1397.
  13. Mazus A.I., et al. “Features of the neurological manifestations of HIV infection”. Clinical Neurology 3 (2009): 31-32.
  14. Khoreva M.A., et al. “Neurological masks of HIV infection”. International Research Journal 67 (2018): 65-69.
  15. Robertson K., et al. “Antiretroviral neurotoxicity”. The Journal of Neuro Virology 5 (2012): 388-399.
  16. Blokhuis C., et al. “Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives”. Neurobehavioral HIV Medicine 7 (2016): 1-13.
  17. Clinical protocol for the treatment of opportunistic infections and HIV-associated diseases in HIV-infected and AIDS-infected children”. Ministry of Health of Ukraine Order № 206 of 07/04 (2006.): 81-82.
  18. Laughton B., et al. “Early antiretroviral therapy improves neurodevelopmental outcomes in infants”. AIDS 13 (2012): 1685-1690.
  19. Jeremy RJ., et al. “Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children”. Pediatrics2 (2005): 380-387.
  20. Shilov GN., et al. “TV MRI aspects of the neuroimaging of CNS lesions in HIV infection”. Medical News 12 (2012): 55-57.
  21. Seliverstov YuA and Klyushnikov SA. “Differential diagnosis of chorea”. Nervous Diseases 1 (2015): 6-15.
  22. Piccolo I ., et al. “Cause and course in a series of patient with sporadic chorea”. Journal of Neurology 250 (2003): 429.
  23. Sporer B., et al. “HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT”. Journal of Neurology 3 (2005): 356-358.


Citation: Badogina LP., et al. “Hyperkinetic Syndrome in Adolescent with HIV-Infection”. Acta Scientific Paediatrics 3.5 (2020): 09-12.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US